Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanotechnology
Volume 2015, Article ID 848020, 8 pages
http://dx.doi.org/10.1155/2015/848020
Research Article

and Relaxivities of Dendrons Based on a OEG-DTPA Architecture: Effect of Gd3+ Placement and Dendron Functionalization

1Institute for Research in Biomedicine, Baldiri Reixac 10, 08028 Barcelona, Spain
2Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain
3Combinatorial Chemistry Unit, Barcelona Science Park, Baldiri Reixac 10, 08028 Barcelona, Spain
4Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Unitat de Biociències, Edifici C, 08193 Cerdanyola del Vallès, Spain
5Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain
6Department of Organic Chemistry, University of Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
7School of Chemistry & Physics, University of KwaZulua-Natal, Durban 4001, South Africa

Received 23 December 2014; Revised 23 February 2015; Accepted 23 February 2015

Academic Editor: Paresh Chandra Ray

Copyright © 2015 Peter Fransen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Caravan, “Strategies for increasing the sensitivity of gadolinium based MRI contrast agents,” Chemical Society Reviews, vol. 35, no. 6, pp. 512–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Cavalli, D. Carbajo, M. Acosta et al., “Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents,” Chemical Communications, vol. 48, no. 43, pp. 5322–5324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Laurent, D. Forge, M. Port et al., “Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations and biological applications,” Chemical Reviews, vol. 108, no. 6, pp. 2064–2110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Yang, Y. Zhuang, Y. Sun et al., “Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles,” Biomaterials, vol. 32, no. 20, pp. 4584–4593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Laurent, L. Vander Elst, F. Botteman, and R. N. Muller, “An assessment of the potential relationship between the charge of Gd-DTPA complexes and the exchange rate of the water coordinated to the metal,” European Journal of Inorganic Chemistry, vol. 2008, pp. 4369–4379, 2008. View at Google Scholar
  6. S. Laus, R. Ruloff, É. Tóth, and A. E. Merbach, “GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents,” Chemistry, vol. 9, no. 15, pp. 3555–3566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-T. Yang and K.-H. Chuang, “Gd(iii) chelates for MRI contrast agents: from high relaxivity to ‘smart’, from blood pool to blood-brain barrier permeable,” MedChemComm, vol. 3, no. 5, pp. 552–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Luo, G. Liu, B. He et al., “Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes,” Biomaterials, vol. 32, no. 10, pp. 2575–2585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Han, J. Li, S. Huang et al., “Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent,” Biomaterials, vol. 32, no. 11, pp. 2989–2998, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kobayashi and M. W. Brechbiel, “Dendrimer-based nanosized MRI contrast agents,” Current Pharmaceutical Biotechnology, vol. 5, no. 6, pp. 539–549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Longmire, P. L. Choyke, and H. Kobayashi, “Dendrimer-based contrast agents for molecular imaging,” Current Topics in Medicinal Chemistry, vol. 8, no. 14, pp. 1180–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Menjoge, R. M. Kannan, and D. A. Tomalia, “Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications,” Drug Discovery Today, vol. 15, no. 5-6, pp. 171–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Fransen, D. Pulido, C. Sevrin, C. Grandfils, F. Albericio, and M. Royo, “High control, fast growth OEG-based dendron synthesis via a sequential two-step process of copper-free diazo transfer and click chemistry,” Macromolecules, vol. 47, no. 8, pp. 2585–2591, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Pulido, F. Albericio, and M. Royo, “Controlling multivalency and multimodality: up to pentamodal dendritic platforms based on diethylenetriaminepentaacetic acid cores,” Organic Letters, vol. 16, no. 5, pp. 1318–1321, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Simón-Gracia, D. Pulido, C. Sevrin, C. Grandfils, F. Albericio, and M. Royo, “Biocompatible, multifunctional, and well-defined OEG-based dendritic platforms for biomedical applications,” Organic & Biomolecular Chemistry, vol. 11, no. 24, pp. 4109–4121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Laurent, C. Henoumont, L. Vander Elst, and R. N. Muller, “Synthesis and physicochemical characterisation of Gd-DTPA derivatives as contrast agents for MRI,” European Journal of Inorganic Chemistry, no. 12, pp. 1889–1915, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Fulton, M. O'Halloran, D. Parker, K. Senanayake, M. Botta, and S. Aime, “Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates,” Chemical Communications, no. 4, pp. 474–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Fulton, E. M. Elemento, S. Aime, L. Chaabane, M. Botta, and D. Parker, “Glycoconjugates of gadolinium complexes for MRI applications,” Chemical Communications, no. 10, pp. 1064–1066, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Caravan, C. T. Farrar, L. Frullano, and R. Uppal, “Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents,” Contrast Media and Molecular Imaging, vol. 4, no. 2, pp. 89–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. P. Candiota, M. Acosta, R. V. Simões et al., “A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study,” Journal of Nanobiotechnology, vol. 12, no. 1, article 12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Rudovský, P. Hermann, M. Botta, S. Aime, and I. Lukes, “Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion,” Chemical Communications, no. 18, pp. 2390–2392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Botta, “Second coordination sphere water molecules and relaxivity of gadolinium(III) complexes: implications for MRI contrast agents,” European Journal of Inorganic Chemistry, no. 3, pp. 399–407, 2000. View at Google Scholar · View at Scopus
  23. T. Courant, V. G. Roullin, C. Cadiou et al., “Hydrogels incorporating GdDOTA: towards highly efficient dual T 1/T2 MRI contrast agents,” Angewandte Chemie—International Edition, vol. 51, no. 36, pp. 9119–9122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Klemm, W. C. Floyd III, C. M. Andolina, J. M. J. Frechet, and K. N. Raymond, “Conjugation to biocompatible dendrimers increases lanthanide relaxivity of hydroxypyridinone (HOPO) complexes for magnetic resonance imaging (MRI),” European Journal of Inorganic Chemistry, vol. 2012, no. 112, pp. 2108–2114, 2012. View at Publisher · View at Google Scholar
  25. P. J. Klemm, W. C. Floyd, D. E. Smiles, J. M. J. Fréchet, and K. N. Raymond, “Improving T1 and T2 magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes,” Contrast Media and Molecular Imaging, vol. 7, no. 1, pp. 95–99, 2012. View at Publisher · View at Google Scholar · View at Scopus